When Clinical Trials Fail to Address Treatment Gaps: The Failure of Niacin-Laropiprant to Reduce Cardiovascular Events

Clinical Trial Report

DOI: 10.1007/s11883-013-0332-x

Cite this article as:
Rosenson, R.S. & Gotto, A.M. Curr Atheroscler Rep (2013) 15: 332. doi:10.1007/s11883-013-0332-x

Keywords

Niacin Laropriprant Simvastatin Cardiovascular events Clinical trials 

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Icahn School of MedicineMount SinaiNew YorkUSA
  2. 2.Weill Cornell Medical CollegeCornell UniversityNew YorkUSA